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Dyschromatosis symmetrica hereditaria (DSH) is an autosomal dominant skin disorder. It is also called ‘‘reticulate
acropigmentation of Dohi’’ or ‘‘symmetric dyschromatosis of the extremities’’. The DSH locus has recently been
mapped to chromosome 1q21 and pathogenic mutations were identiﬁed in the DSRAD gene encoding double-
stranded RNA-speciﬁc adenosine deaminase in Japanese patients with DSH. We report here two novel point
mutations, Q513X(1537C4T) and R916W(2746C4T) in the DSRAD gene identiﬁed in two Chinese families,
respectively. These data suggest that mutations in DSRAD were also associated with DSH in Chinese. This is the
ﬁrst report on DSRAD as the causative gene of DSH in the Chinese population.
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Dyschromatosis symmetrica hereditaria (DSH, MIM 127400)
is an autosomal dominant skin disorder, characterized by
the presence of hyperpigmented and hypopigmented
macules mostly on the dorsal aspects of the extremities.
On the face, the lesions resemble ephelides and no
hypopigmentation appears. These skin lesions are other-
wise asymptomatic and are not associated with other
manifestations. The onset of the disease is usually during
infancy or childhood and 73% of patients develop the skin
lesions before 6 y of age (Oyama et al, 1999). DSH was
reported mainly in Japan and was also called ‘‘reticulate
acropigmentation of Dohi’’ or ‘‘symmetric dyschromatosis
of the extremities’’ in the literature. Histological studies
indicated that melanocyte count might be decreased in the
entire involved skin area irrespective of its color changes
(Sheu and Yu, 1985), whereas melanocytes in the hyper-
pigmented regions were in a hyperactive metabolic state.
The DSH locus has recently been mapped to chromo-
some 1q21 by Chinese and Japanese workers, indepen-
dently (Miyamura et al, 2003, Zhang et al, 2003). Pathogenic
mutations were identified in the DSRAD gene encoding
double-stranded RNA-specific adenosine deaminase in
Japanese patients with DSH. In this report, we describe
two typical Chinese families affected with DSH in which two
heterozygous mutations were identified. Our results suggest
mutations in DSRAD were also associated with DSH in
Chinese.
Results
Clinical ﬁndings The clinical manifestations of the two
families were similar as described previously (Miyamura
et al, 2003; Zhang et al, 2003). Family 1 was a large five-
generation one consisting of 30 individuals (Fig 1A) and
family 2 was a three-generation one consisting of seven
individuals (Fig 1B). All affected individuals showed typical
DSH skin lesions as indicated in Fig 2A. Upon prolonged
sun exposure in the summer or after skin injury, the lesions
may become aggravated. Besides the unpleasant appear-
ance, the lesions did not produce other symptoms. The skin
lesions in family 1 all appeared before childhood, generally
by 7–8 y of age, whereas the onset of disease for the
proband of family 2 was by 3 y of age. The proband of family
1, IV-8, was a 42-y-old female and the onset of DSH was
around 7 y of age. She developed hyperpigmented and
hypopigmented macules on the dorsal aspects of her hands
and feet, and around her wrists and ankles. These lesions
were irregular in shape and size. Small freckle-like pigmen-
ted macules were observed on her face. Other affected
individuals in family 1 showed similar manifestations. III3,
the eldest in the family available for clinical evaluation, was
the most severely affected. He developed symmetrical
hyperpigmented and hypopigmented macules on the whole
arms and the part of two legs below knee joints. In addition,
IV3 showed skin lesions on her neck and IV6 had a few1These two authors contributed equally to this work.
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small hyperpigmented macules around the elbow and knee
joints. The proband of family 2 was a 25-y-old male. Apart
from the extremities and the face, he also showed slight
skin lesions around the elbow and knee joints. His father
showed similar but more severe eruptions. The unpleasant
macules also appeared on his forearms and shanks. He had
a definite history of measles at the age of 30 y after which
the typical skin lesions of DSH developed.
Linkage analysis We typed all 20 individuals of family 1
(Fig 1A) with the five markers from the candidate region of
the DSH locus. A maximum LOD score was obtained for
marker D1S534 (Zmax¼3.25, y¼0.00), showing definitive
evidence of linkage. LOD scores of two other markers,
D1S1600 (Zmax¼2.23, y¼ 0.00) and D1S3466 (Zmax¼2.33,
y¼ 0.00) were also suggestive. Haplotype analysis showed
no recombination.
Identiﬁcation of novel DSRAD mutation Based on the
recent findings of pathogenic mutations in DSRAD in four
Japanese DSH families (Miyamura et al, 2003), we looked
for mutations of this gene in the two Chinese families
affected with DSH. In family 1, a heterozygous nonsense
mutation, Q513X(1537C4T) in exon 2 was detected by
direct sequencing of the PCR products (Fig 2B). For
confirmation of this point mutation, we introduced into the
513X(1537T) mutant allele an SpeI recognition sequence
(50-ACTAGT-30) using a mismatch primer E2F4 in the semi-
Figure 1
Family pedigrees. (A) Family 1. (B) Family 2.
Figure 2
Typical skin lesions and mutations of the double-stranded RNA-
specific adenosine deaminase (DSRAD) gene. (A) Typical macules
on the dorsal aspects of hands and feet. The 25-y-old proband of family
2 (II3). (B) DNA sequence of DSRAD exon 2 showing Q513X(1537C4T)
mutation in family 1. (C) DNA sequence of DSRAD exon 9 showing
R916W(2746C4T) mutation in family 2. (D) Confirmation of
Q513X(1537C4T) by SpeI digestion in family 1. M is a 50 bp DNA
ladder; the SpeI digests of the semi-nested PCR products derived from
all available family members are indicated by the corresponding
numbers in Fig 1A. (E) Confirmation of R916W(2746C4T) by MspI
digestion. M is a 50 bp DNA ladder; P is the proband of family 2; 1–19
are unrelated, normally pigmented individuals. (F) Schematic maps of
the DSRAD gene and its encoded protein. Localizations of the
mutations identified in Japanese families (italic) and in our present
report (bold) are indicated. NES, nuclear export signal; Z, Z-DNA-
binding motif; DRBMs, dsRNA-binding motifs.
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nested PCR. The created SpeI restriction enzyme site was
applied in subsequent enzymatic examination in all avail-
able members of family 1 as well as 70 normal individuals.
Besides the normal 163 bp DNA fragment, a 134 bp
fragment could be seen in all the patients after restriction
enzyme digestion. In the normally pigmented persons, no
134 bp fragment was observed. The mutation was thus
confirmed in the other 10 patients and excluded in the
remaining nine unaffected persons in family 1 (Fig 2D) and
70 normal individuals (data not shown). Only the proband
in family 2 was available for mutation detection. Accord-
ing to direct sequence analysis of the PCR products of
exon 9, an R916W(2746C4T) missense mutation in DSRAD
was identified (Fig 2C), which was located in the
highly conserved region of the deaminase domain.
R916W(2746C4T) could be detected in sequence analysis
using both forward and reverse primers. R916W(2746C4T)
destroyed one of the three MspI sites within the fragment
amplified using primers E9F and E9R. MspI digests of the
wild-type fragment and the 916W(2746T) mutant one
showed bands of 180 and 221 bp, respectively, upon
polyacrylamide gel electrophoresis. A single 180 bp frag-
ment was detected in all 70 normal individuals whereas
both fragments could be clearly observed in the proband
(Fig 2E). This indicated that the proband was heterozygous
for the mutation. The two mutations we identified were
not detected in Japanese families (Miyamura et al, 2003;
Fig 2F).
Discussion
Skin lesions observed in the present two Chinese DSH
families appear predominantly on the backs of the hands
and the tops of the feet. These are typical clinical
manifestations as described previously (Oyama et al,
1999; Miyamura et al, 2003; Zhang et al, 2003). Through
two-point linkage analysis in family 1, we obtained a
maximum LOD score of 3.25 at marker D1S534 (y¼ 0.00),
suggesting the genetic mapping of the disease locus to the
chromosome region reported by Chinese and Japanese
groups (Miyamura et al, 2003; Zhang et al, 2003). These
result further confirmed clinical and genetic homogeneity of
DSH. When skin lesions similar to those of DSH occur
predominantly on the trunk or all over the body, the disease
is called dyschromatosis universalis hereditaria (DUH, MIM
127500). According to the suspected DSH locus at
chromosome 6q24.2–q25.2 as recently reported by another
Chinese group (Xing et al, 2003), we also screened this
region with four microsatellite markers and got negative
LOD scores (data not shown). Considering the clinical
features of patients reported by Xing et al (2003), it is more
likely to be DUH.
DSRAD is an RNA modifying enzyme that was discov-
ered upon performing antisense experiments in Xenopus
laevis (Rebagliati and Melton, 1987). It is developmentally
regulated and is important for various functions such as
site-specific RNA editing (Bass, 2002) and nuclear transla-
tion (Herbert et al, 2002). The human DSRAD gene spans 30
kb and contains 15 exons (Wang et al, 1995). Its encoded
protein is composed of 1226 amino acids with a calculated
molecular weight of 139 kDa (O’Connell et al, 1995). During
our screening for the candidate genes in chromosome
1q11–q21 region, Miyamura et al (2003) reported their
discovery of the disease gene DSRAD. The four mutations
identified in four different Japanese DSH families were in
exons 2, 10, 10, and 15 with two nonsense mutations and
two missense mutations each. We therefore screened the
DSRAD gene in our two Chinese DSH families and detected
two new heterozygous mutations, Q513X(1537C4T) and
R916W(2746C4T). Q513X(1537C4T) was shown to seg-
regate with patients showing DSH lesions but was not
detectable in normally pigmented individuals in family 1.
Neither of the two mutations was detected in the 70
normally pigmented individuals.
The DSRAD encoded protein contains, from N- to
C-terminals, a nuclear export signal, two Z-DNA-binding
motifs, three dsRNA-binding motifs (DRBMs) and a catalytic
domain (Fig 2F). Since Q513X(1537C4T) mutation was
found in DRBM1 and could cause protein truncation,
conceivably, it must underlie the pathogenesis of DSH in
family 1. Additionally, R916W(2746C4T) changed one of
the highly conserved amino acid residues in the putative
deaminase catalytic domain. The arginine at 916 is
absolutely conserved among the 11 different species from
Homo sapiens to Caenorhabditis elegans (Miyamura et al,
2003). The mutation resulted in a replacement of the basic
hydrophilic arginine (R) by the nonpolar hydrophobic
tryptophan (W). Given the fact that another missense
mutation (L923P) in the same highly conserved region was
also detected in a Japanese DSH family (Miyamura et al,
2003), we believe R916W (2746C4T) is the pathogenic
mutation in our family 2. Furthermore, no obvious genotype/
phenotype correlations were observed in our two families
probably because only two DSH families were analyzed.
Homodimerization was recently demonstrated to be essen-
tial for the enzyme activity of the DSRAD encoded protein
(Cho et al, 2003). Both of the DRBMs and the catalytic
domain were suggested to be required for formation of the
homodimer (Cho et al, 2003). Therefore, mutations de-
scribed in our present report and found in Japanese DSH
families may be dominant negative. Alternatively, it might be
also possible that nonsense-mediated RNA decay occurred
and that DSRAD haploinsufficiency could also lead to DSH.
Taken together, we have identified two novel DSRAD
mutations in Chinese DSH families, suggesting that muta-
tions in DSRAD were also associated with DSH in Chinese.
Materials and Methods
Peripheral blood samples were collected from two Chinese families
with DSH after informed consent of family members and approval
of PUMC Institutional Review Board were obtained. Genomic DNA
was extracted from blood samples using standard SDS–proteinase
K–phenol/chloroform method. Two-point linkage analysis was
performed in family 1 using five polymorphic microsatellite markers
(D1S534, D1S2343, D1S1156, D1S3466, and D1S1600 with an
average distance of 4.0 cM in between them). All 15 coding exons
and their flanking intronic sequences of the DSRAD gene were
amplified by PCR and were then subjected to automatic DNA
sequencing after purification (primer sequences are available
on request). To confirm mutation in family 1, genomic DNA was
first amplified using primers E2F3: 50-AACCGCTCCAGCTG-
898 LIU ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
CAATCCCTGAG-30 and E2R: 50-TCAGCCAAGACTGCGTCAG-
GAGC-30. The amplified products were used as templates for the
subsequent semi-nested PCR using primers E2F4: 50-CCAT-
CAGCGGGCGTTAGAATATGAC-30 and E2R to create an SpeI
restriction site in the 513X (1537T) mutant allele through primer
E2F4. The amplicons derived from the semi-nested PCR were
digested with SpeI restriction enzyme (TaKaRa Biotech, Dalian,
China) and analyzed by electrophoresis through 8% polyacryla-
mide gel. To ascertain the mutation in family 2, PCR fragments
amplified using primers E9F: 50-CTGAGGCTGTTTCTGCCTT-
GAAGC-30 and E9R: 50-GGGAACTGGAGCTCTCCACAG-30 were
further subjected to restriction analysis with MspI enzyme (TaKaRa
Biotech). DNA samples available from 70 unrelated, normally
pigmented adult individuals were also included in the restriction
analyses with SpeI and MspI enzymes.
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